Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Rehm

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Anesthesiology|October 25, 2017
No Differences in Renal Function between Balanced 6% Hydroxyethyl Starch (130/0.4) and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy: A Randomized Controlled TrialTobias Kammerer, Florian Brettner, Sebastian Hilferink, et al.
The FEBS Journal|March 4, 2021
Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancerChristopher McCann, Anna Matveeva, Katherine McAllister, et al.
Cell Death and Differentiation|March 4, 2018
Simulating and predicting cellular and in vivo responses of colon cancer to combined treatment with chemotherapy and IAP antagonist Birinapant/TL32711Nyree Crawford, Manuela Salvucci, Christian T Hellwig, et al.
Circulation|October 10, 2007
Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemiaMarkus Rehm, Dirk Bruegger, Frank Christ, et al.
Thrombosis Research|November 3, 2019
Effects of balanced hydroxyethyl starch 6% (130/0.4) and albumin 5% on clot formation and glycocalyx shedding: Subgroup analysis of a prospective randomized trialTobias Kammerer, Nikolai Hulde, Eike Speck, et al.
Molecular Pharmacology|August 29, 2009
Bid and calpains cooperate to trigger oxaliplatin-induced apoptosis of cervical carcinoma HeLa cellsSergio Anguissola, Barbara Köhler, Robert O'Byrne, et al.
Cell Death and Differentiation|October 17, 2018
Phosphoprotein patterns predict trametinib responsiveness and optimal trametinib sensitisation strategies in melanomaJan Rožanc, Theodore Sakellaropoulos, Asier Antoranz, et al.
Cell Death and Differentiation|April 29, 2025
Interplay of ferroptotic and apoptotic cell death and its modulation by BH3-mimeticsYun Qiu, Juliana A Hüther, Bianca Wank, et al.
Clinical Hemorheology and Microcirculation|February 6, 2018
Chances and limitations of isolated mouse heart models for investigating the endothelial glycocalyx1Florian Brettner, Joshua Darling, Edith-Cathrin Baeuml, et al.
Journal of Cell Science|November 22, 2021
Cell cycle progression and transmitotic apoptosis resistance promote escape from extrinsic apoptosisNadine Pollak, Aline Lindner, Dirke Imig, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Anesthesiology|October 25, 2017
No Differences in Renal Function between Balanced 6% Hydroxyethyl Starch (130/0.4) and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy: A Randomized Controlled TrialTobias Kammerer, Florian Brettner, Sebastian Hilferink, et al.
The FEBS Journal|March 4, 2021
Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancerChristopher McCann, Anna Matveeva, Katherine McAllister, et al.
Cell Death and Differentiation|March 4, 2018
Simulating and predicting cellular and in vivo responses of colon cancer to combined treatment with chemotherapy and IAP antagonist Birinapant/TL32711Nyree Crawford, Manuela Salvucci, Christian T Hellwig, et al.
Circulation|October 10, 2007
Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemiaMarkus Rehm, Dirk Bruegger, Frank Christ, et al.
Thrombosis Research|November 3, 2019
Effects of balanced hydroxyethyl starch 6% (130/0.4) and albumin 5% on clot formation and glycocalyx shedding: Subgroup analysis of a prospective randomized trialTobias Kammerer, Nikolai Hulde, Eike Speck, et al.
Molecular Pharmacology|August 29, 2009
Bid and calpains cooperate to trigger oxaliplatin-induced apoptosis of cervical carcinoma HeLa cellsSergio Anguissola, Barbara Köhler, Robert O'Byrne, et al.
Cell Death and Differentiation|October 17, 2018
Phosphoprotein patterns predict trametinib responsiveness and optimal trametinib sensitisation strategies in melanomaJan Rožanc, Theodore Sakellaropoulos, Asier Antoranz, et al.
Cell Death and Differentiation|April 29, 2025
Interplay of ferroptotic and apoptotic cell death and its modulation by BH3-mimeticsYun Qiu, Juliana A Hüther, Bianca Wank, et al.
Clinical Hemorheology and Microcirculation|February 6, 2018
Chances and limitations of isolated mouse heart models for investigating the endothelial glycocalyx1Florian Brettner, Joshua Darling, Edith-Cathrin Baeuml, et al.
Journal of Cell Science|November 22, 2021
Cell cycle progression and transmitotic apoptosis resistance promote escape from extrinsic apoptosisNadine Pollak, Aline Lindner, Dirke Imig, et al.
Pageof 17